JONATHAN EDWARD BRADD NP
Prescription History 1760034607
Nurse Practitioner in Grand Rapids, MI
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for JONATHAN EDWARD BRADD NP, an active Nurse Practitioner specialist practicing in Grand Rapids, MI. Our medical registry currently tracks 11 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 883 documented patient claims. Among these therapy options, the most frequently utilized medication is Tamsulosin Hcl, which accounts for 475 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other MI PrescribersVs. MI Avg |
|---|---|---|---|
| Tamsulosin Hcl | 475 | $29.40 | ▲ More than typical |
About Tamsulosin Hcl: Tamsulosin is used by men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia-BPH). Show more ▾ It does not shrink the prostate, but it works by relaxing the muscles in the prostate and the bladder. This helps to relieve symptoms of BPH such as difficulty in beginning the flow of urine, weak stream, and the need to urinate often or urgently (including during the middle of the night). Tamsulosin belongs to a class of drugs known as alpha blockers. Do not use this medication to treat high blood pressure. A sulfonamide derivative and adrenergic alpha-1 receptor antagonist that is used to relieve symptoms of urinary obstruction caused by BENIGN PROSTATIC HYPERPLASIA. In 2024, this provider wrote 475 Medicare prescriptions for Tamsulosin Hcl, about 5.5 times the volume of the typical Michigan prescriber of this medication (86.6). Medicare paid an average of $29.40 per fill, versus $19.34 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 1,301.1 30-Day Fills standardized to 30-day supplies 38,940 Days of Medication total across all patients in 2024 | |||
| Dutasteride | 166 | $41.67 | ▲ More than typical |
About Dutasteride: This medication is used in men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia-BPH). Show more ▾ It works by reducing the size of the enlarged prostate. This helps to relieve symptoms of BPH such as difficulty in beginning the flow of urine, weak stream, and the need to urinate often or urgently (including during the middle of the night). It may also reduce the need for surgery to treat BPH. Dutasteride is not approved for prevention of prostate cancer. It may slightly increase the risk of developing a very serious form of prostate cancer. Talk to your doctor about the benefits and risks. This medication should not be used by women or children. A 5-ALPHA-REDUCTASE INHIBITOR that is reported to inhibit both type-1 and type2 isoforms of the enzyme and is used to treat BENIGN PROSTATIC HYPERPLASIA. In 2024, this provider wrote 166 Medicare prescriptions for Dutasteride, about 5.1 times the volume of the typical Michigan prescriber of this medication (32.5). Medicare paid an average of $41.67 per fill, versus $37.58 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 492 30-Day Fills standardized to 30-day supplies 14,756 Days of Medication total across all patients in 2024 | |||
| Finasteride | 48 | $15.14▼ below MI avg | ≈ Typical |
About Finasteride: Finasteride is used to shrink an enlarged prostate (benign prostatic hyperplasia or BPH) in adult men. Show more ▾ It may be used alone or taken in combination with other medications to reduce symptoms of BPH and may also reduce the need for surgery. Finasteride may improve symptoms of BPH and provide benefits such as decreased urge to urinate, better urine flow with less straining, less of a feeling that the bladder is not completely emptied, and decreased nighttime urination. This medication works by decreasing the amount of a natural body hormone (DHT) that causes growth of the prostate. Finasteride is not approved for prevention of prostate cancer. It may slightly increase the risk of developing a very serious form of prostate cancer. Talk to your doctor about the benefits and risks. Women and children should not use this medication. An orally active 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE inhibitor. It is used as a surgical alternative for treatment of benign PROSTATIC HYPERPLASIA. In 2024, this provider wrote 48 Medicare prescriptions for Finasteride, about the same volume as the typical Michigan prescriber of this medication (50.1). Medicare paid an average of $15.14 per fill, versus $17.21 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MI average for this medication. 144 30-Day Fills standardized to 30-day supplies 4,320 Days of Medication total across all patients in 2024 | |||
| MyrbetriqMirabegron | 34 | $911.51 | ≈ Typical |
About Myrbetriq: This medication is used to treat certain bladder problems (overactive bladder, neurogenic detrusor overactivity). Show more ▾ Overactive bladder is a problem with how your bladder stores urine. Neurogenic detrusor overactivity is a bladder control condition caused by brain, spinal cord, or nerve problems. Symptoms of these conditions may include frequent urination, strong sudden urges to urinate that are hard to control, or involuntary loss of urine (incontinence). Mirabegron works by relaxing a certain bladder muscle (detrusor), which helps the bladder hold more urine and lessens symptoms of overactive bladder and neurogenic detrusor overactivity. A beta3-adrenergic receptor agonist. In 2024, this provider wrote 34 Medicare prescriptions for Myrbetriq, about 86% of the volume of the typical Michigan prescriber of this medication (39.7). Medicare paid an average of $911.51 per fill, versus $681.06 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 74 30-Day Fills standardized to 30-day supplies 2,220 Days of Medication total across all patients in 2024 | |||
| Testosterone | 33 | $94.45▼ below MI avg | ▲ More than typical |
About Testosterone: This medicated gel contains testosterone. Show more ▾ It is used for hormone replacement in men who are not able to produce enough testosterone (for example, due to hypogonadism). This medication is absorbed through the skin, enters your bloodstream, and helps your body reach normal testosterone levels. Testosterone helps the body to develop and maintain the male sexual characteristics (masculinity), such as a deep voice and body hair. It also helps to maintain muscle and prevent bone loss, and is necessary for natural sexual ability/desire. This drug should not be used by women. A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL. In 2024, this provider wrote 33 Medicare prescriptions for Testosterone, about 1.6 times the volume of the typical Michigan prescriber of this medication (20.1). Medicare paid an average of $94.45 per fill, versus $170.20 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MI average for this medication. 38.9 30-Day Fills standardized to 30-day supplies 1,048 Days of Medication total across all patients in 2024 | |||
| GemtesaVibegron | 28 | $826.63 | ▼ Less than typical |
About Gemtesa: This medication is used to treat overactive bladder. Show more ▾ Overactive bladder is a problem with how your bladder stores urine that causes a sudden urge to urinate. The urge may be hard to control, and overactive bladder symptoms may include frequent urination, strong sudden urges to urinate, or involuntary loss of urine (incontinence). Vibegron works by relaxing a certain bladder muscle (detrusor), which helps the bladder hold more urine and lessens symptoms of overactive bladder. A beta3 adrenergic receptor agonist. In 2024, this provider wrote 28 Medicare prescriptions for Gemtesa, about half the volume of the typical Michigan prescriber of this medication (50.6). Medicare paid an average of $826.63 per fill, versus $676.45 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 50 30-Day Fills standardized to 30-day supplies 1,500 Days of Medication total across all patients in 2024 | |||
| Testosterone Cypionate | 26 | $42.62 | ≈ Typical |
About Testosterone Cypionate: This medication is used in men who do not make enough of a natural substance called testosterone. Show more ▾ In males, testosterone is responsible for many normal functions, including growth and development of the genitals, muscles, and bones. It also helps cause normal sexual development (puberty) in boys. Testosterone belongs to a class of drugs known as androgens. It works by affecting many body systems so that the body can develop and function normally. Testosterone may also be used in certain adolescent boys to cause puberty in those with delayed puberty. Some brands may also be used to treat certain types of breast cancer in women. A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL. In 2024, this provider wrote 26 Medicare prescriptions for Testosterone Cypionate, about the same volume as the typical Michigan prescriber of this medication (23.9). Medicare paid an average of $42.62 per fill, versus $34.71 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 45.3 30-Day Fills standardized to 30-day supplies 1,265 Days of Medication total across all patients in 2024 | |||
| Solifenacin Succinate | 22 | $55.47 | ▼ Less than typical |
About Solifenacin Succinate: Solifenacin is used to treat an overactive bladder. Show more ▾ By relaxing the muscles in the bladder, solifenacin improves your ability to control your urination. It helps to reduce leaking of urine, feelings of needing to urinate right away, and frequent trips to the bathroom. This medication belongs to the class of drugs known as antispasmodics. A quinuclidine and tetrahydroisoquinoline derivative and selective M3 MUSCARINIC ANTAGONIST. It is used as a UROLOGIC AGENT in the treatment of URINARY INCONTINENCE. In 2024, this provider wrote 22 Medicare prescriptions for Solifenacin Succinate, about 70% of the volume of the typical Michigan prescriber of this medication (31.4). Medicare paid an average of $55.47 per fill, versus $40.51 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 62 30-Day Fills standardized to 30-day supplies 1,860 Days of Medication total across all patients in 2024 | |||
| Potassium Citrate ErPotassium Citrate | 20 | $66.55▼ below MI avg | ▼ Less than typical |
About Potassium Citrate Er: This medication is used to make the urine less acidic. Show more ▾ This effect helps the kidneys get rid of uric acid, thereby helping to prevent gout and kidney stones. This medication can also prevent and treat certain metabolic problems (acidosis) caused by kidney disease. Citric acid and citrate salts (which contain potassium and sodium) belong to a class of drugs known as urinary alkalinizers. If you have a condition that requires you to limit your intake of potassium and sodium, your doctor may direct you to take a product that is lower in potassium and sodium. A powder that dissolves in water, which is administered orally, and is used as a diuretic, expectorant, systemic alkalizer, and electrolyte replenisher. In 2024, this provider wrote 20 Medicare prescriptions for Potassium Citrate Er, about 73% of the volume of the typical Michigan prescriber of this medication (27.3). Medicare paid an average of $66.55 per fill, versus $113.44 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MI average for this medication. 44 30-Day Fills standardized to 30-day supplies 1,304 Days of Medication total across all patients in 2024 | |||
| Trospium Chloride | 17 | $54.56▼ below MI avg | ▼ Less than typical |
About Trospium Chloride: This medication is used to treat an overactive bladder. Show more ▾ By relaxing the muscles in the bladder, trospium improves your ability to control your urination. It helps to reduce leaking of urine, feelings of needing to urinate right away, and frequent trips to the bathroom. Trospium belongs to a class of drugs known as antispasmodics. It is also known as an antimuscarinic. In 2024, this provider wrote 17 Medicare prescriptions for Trospium Chloride, about half the volume of the typical Michigan prescriber of this medication (31.9). Medicare paid an average of $54.56 per fill, versus $65.13 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MI average for this medication. 45 30-Day Fills standardized to 30-day supplies 1,350 Days of Medication total across all patients in 2024 | |||
| Alfuzosin Hcl ErAlfuzosin Hcl | 14 | $17.70▼ below MI avg | ▼ Less than typical |
About Alfuzosin Hcl Er: Alfuzosin is used by men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia-BPH). Show more ▾ It does not shrink the prostate, but it works by relaxing the muscles in the prostate and the bladder. This helps to relieve symptoms of BPH such as difficulty in beginning the flow of urine, weak stream, and the need to urinate often or urgently (including during the middle of the night). Alfuzosin belongs to a class of drugs known as alpha blockers. Do not use this medication to treat high blood pressure. In 2024, this provider wrote 14 Medicare prescriptions for Alfuzosin Hcl Er, about a third of the volume of the typical Michigan prescriber of this medication (41.5). Medicare paid an average of $17.70 per fill, versus $29.85 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MI average for this medication. 40 30-Day Fills standardized to 30-day supplies 1,200 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for JONATHAN EDWARD BRADD NP is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Nurse Practitioner prescribing approach at this Grand Rapids, MI practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among MI prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
